Intervacc
1 known investors
Intervacc is a Swedish biotech company that develops animal health vaccines based on fusions of recombinant proteins, including Strangvac® against strangles in horses. Through its subsidiaries Nordvacc Läkemedel and Mybac-Vettech Laboratoriet, it sells animal vaccines on the European animal health market.